AAAAAA

   
Results: 1-23 |
Results: 23
UP-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN SEVERE CHRONICBRAIN HYPOXIA OF THE RAT
Authors: PATT S DANNER S THEALLIERJANKO A BREIER G HOTTENROTT G PLATE KH CERVOSNAVARRO J
Citation: S. Patt et al., UP-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN SEVERE CHRONICBRAIN HYPOXIA OF THE RAT, Neuroscience letters, 252(3), 1998, pp. 199-202
THE DURATION OF VIRAL SUPPRESSION DURING PROTEASE INHIBITOR THERAPY FOR HIV-1 INFECTION IS PREDICTED BY PLASMA HIV-1 RNA AT THE NADIR
Authors: KEMPF DJ RODE RA XU Y SUN E HEATHCHIOZZI ME VALDES J JAPOUR AJ DANNER S BOUCHER C MOLLA A LEONARD JM
Citation: Dj. Kempf et al., THE DURATION OF VIRAL SUPPRESSION DURING PROTEASE INHIBITOR THERAPY FOR HIV-1 INFECTION IS PREDICTED BY PLASMA HIV-1 RNA AT THE NADIR, AIDS, 12(5), 1998, pp. 9-14
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RITONAVIR IN ADVANCED HIV-1 DISEASE
Authors: CAMERON DW HEATHCHIOZZI M DANNER S COHEN C KRAVCIK S MAURATH C SUN E HENRY D RODE R POTTHOFF A LEONARD J
Citation: Dw. Cameron et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RITONAVIR IN ADVANCED HIV-1 DISEASE, Lancet, 351(9102), 1998, pp. 543-549
MOLECULAR-BASIS OF ADRENERGIC-RECEPTOR FUNCTION
Authors: LOHSE MJ DANNER S KRASEL C WINSTEL R
Citation: Mj. Lohse et al., MOLECULAR-BASIS OF ADRENERGIC-RECEPTOR FUNCTION, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 61-61
AGONIST-REGULATION OF HUMAN BETA(2)-ADRENERGIC RECEPTOR MESSENGER-RNASTABILITY
Authors: DANNER S FRANK M LOHSE MJ
Citation: S. Danner et al., AGONIST-REGULATION OF HUMAN BETA(2)-ADRENERGIC RECEPTOR MESSENGER-RNASTABILITY, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 189-189
AGONIST REGULATION OF HUMAN BETA(2)-ADRENERGIC RECEPTOR MESSENGER-RNASTABILITY OCCURS VIA A SPECIFIC AU-RICH ELEMENT
Authors: DANNER S FRANK M LOHSE MJ
Citation: S. Danner et al., AGONIST REGULATION OF HUMAN BETA(2)-ADRENERGIC RECEPTOR MESSENGER-RNASTABILITY OCCURS VIA A SPECIFIC AU-RICH ELEMENT, The Journal of biological chemistry, 273(6), 1998, pp. 3223-3229
REGULATION OF BETA(2)-ADRENERGIC RECEPTOR MESSENGER-RNA LEVELS
Authors: DANNER S LOHSE MJ
Citation: S. Danner et Mj. Lohse, REGULATION OF BETA(2)-ADRENERGIC RECEPTOR MESSENGER-RNA LEVELS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 195-195
LAMIVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS (184V) REQUIRE MULTIPLE AMINO-ACID CHANGES TO BECOME CO-RESISTANT TO ZIDOVUDINE IN-VIVO
Authors: NIJHUIS M SCHUURMAN R DEJONG D VANLEEUWEN R LANGE J DANNER S KEULEN W DEGROOT T BOUCHER CAB
Citation: M. Nijhuis et al., LAMIVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS (184V) REQUIRE MULTIPLE AMINO-ACID CHANGES TO BECOME CO-RESISTANT TO ZIDOVUDINE IN-VIVO, The Journal of infectious diseases, 176(2), 1997, pp. 398-405
EVALUATION OF SORIVUDINE (BV-ARAU) VERSUS ACYCLOVIR IN THE TREATMENT OF ACUTE LOCALIZED HERPES-ZOSTER IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADULTS
Authors: BODSWORTH NJ BOAG F BURDGE D GENEREUX M BORLEFFS JCC EVANS BA MODAI J COLEBUNDERS R THOMAS M DEHERTOGH D PACELLI L THOMIS J KNIGHT V MCNULTY AM DELANEY C VANHOVE D SACKS S GAGE L MCLEOD A DIAZMITOMA F FONG J MACFADDEN D MARTEL A RACHLIS A SALIT I SHAFRAN S SZABO J TOMA E DESCHENES L GILL J LALONDE R KAUFHOLD R MOLINA JM DELLAMONICA P ROZENBAUM W KOLSTERS FP MEENHORST PL DANNER S SPRENGER HG ELLISPEGLER RB MORAGAS J MOYLE G COLMAN J PARNELL A MCLEAN KA HOLMES DA KITCHEN V LINDE A DAHL H DWYER D
Citation: Nj. Bodsworth et al., EVALUATION OF SORIVUDINE (BV-ARAU) VERSUS ACYCLOVIR IN THE TREATMENT OF ACUTE LOCALIZED HERPES-ZOSTER IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADULTS, The Journal of infectious diseases, 176(1), 1997, pp. 103-111
PHOSDUCIN, POTENTIAL ROLE IN MODULATION OF OLFACTORY SIGNALING
Authors: BOEKHOFF I TOUHARA K DANNER S INGLESE J LOHSE MJ BREER H LEFKOWITZ RJ
Citation: I. Boekhoff et al., PHOSDUCIN, POTENTIAL ROLE IN MODULATION OF OLFACTORY SIGNALING, The Journal of biological chemistry, 272(7), 1997, pp. 4606-4612
CELL-TYPE-SPECIFIC REGULATION OF BETA(2)-ADRENOCEPTOR MESSENGER-RNA BY AGONISTS
Authors: DANNER S LOHSE MJ
Citation: S. Danner et Mj. Lohse, CELL-TYPE-SPECIFIC REGULATION OF BETA(2)-ADRENOCEPTOR MESSENGER-RNA BY AGONISTS, European journal of pharmacology, 331(1), 1997, pp. 73-78
REGULATION OF THE MEGAKARYOCYTIC GLYCOPROTEIN-IX PROMOTER BY GATA-1 AND FLI-1
Authors: BASTIAN LS KWIATKOWSKI B DANNER S ROTH G
Citation: Ls. Bastian et al., REGULATION OF THE MEGAKARYOCYTIC GLYCOPROTEIN-IX PROMOTER BY GATA-1 AND FLI-1, Blood, 90(10), 1997, pp. 3404-3404
EPIDEMIOLOGY OF AIDS DEMENTIA COMPLEX IN EUROPE
Authors: CHIESI A VELLA S DALLY LG PEDERSEN C DANNER S JOHNSON AM SCHWANDER S GOEBEL FD GLAUSER M ANTUNES F LUNDGREN JD
Citation: A. Chiesi et al., EPIDEMIOLOGY OF AIDS DEMENTIA COMPLEX IN EUROPE, Journal of acquired immune deficiency syndromes and human retrovirology, 11(1), 1996, pp. 39-44
MECHANISMS OF BETA-ADRENERGIC-RECEPTOR DESENSITIZATION - FROM MOLECULAR-BIOLOGY TO HEART-FAILURE
Authors: LOHSE MJ ENGELHARDT S DANNER S BOHM M
Citation: Mj. Lohse et al., MECHANISMS OF BETA-ADRENERGIC-RECEPTOR DESENSITIZATION - FROM MOLECULAR-BIOLOGY TO HEART-FAILURE, Basic research in cardiology, 91, 1996, pp. 29-34
REGULATORS OF G-PROTEIN-MEDIATED SIGNALING
Authors: LOHSE MJ BLUML K DANNER S KRASEL C
Citation: Mj. Lohse et al., REGULATORS OF G-PROTEIN-MEDIATED SIGNALING, Biochemical Society transactions, 24(4), 1996, pp. 975-980
WHAT SHOULD WE BE MONITORING IMMUNOLOGICALLY IN ANTIVIRAL TRIALS OTHER THAN CD4-CELL COUNTS( T)
Authors: MIEDEMA F PAKKER N WOLTHERS K KOOT M ROOS M MEYAARD L LANGE J DANNER S SCHELLEKENS P
Citation: F. Miedema et al., WHAT SHOULD WE BE MONITORING IMMUNOLOGICALLY IN ANTIVIRAL TRIALS OTHER THAN CD4-CELL COUNTS( T), AIDS, 10, 1996, pp. 41-41
EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS
Authors: PEDERSEN C DANNER S LAZZARIN A GLAUSER MP WEBER R KATLAMA C BARTON SE LUNDGREN JD CLUMECK N DEWIT S SOMMEREIJNS B NIELSEN JO NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S VELLA S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G EMILIA R CARGNEL A ARLOTTI M CIAMMARUGHI R RIMINI I COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W MONFORTE AD MIGNANI E ANDREA S NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R REISS P ANTUNES F GONZALEZLAHOZ J POLO R CLOTET B GATELL J BUIRA E MIRO J PEHRSON P LUTHY R LEDERGERBER B OLSSON C GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJORUP I NIEPORT C TEGLBJAERG L THORNVAL A
Citation: C. Pedersen et al., EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS, Genitourinary medicine, 72(2), 1996, pp. 128-131
PHOSDUCIN IS A UBIQUITOUS G-PROTEIN REGULATOR
Authors: DANNER S LOHSE MJ
Citation: S. Danner et Mj. Lohse, PHOSDUCIN IS A UBIQUITOUS G-PROTEIN REGULATOR, Proceedings of the National Academy of Sciences of the United Statesof America, 93(19), 1996, pp. 10145-10150
EXPRESSION OF PHOSDUCIN IN A PHOSDUCIN-NEGATIVE CELL-LINE REVEALS FUNCTIONS OF A G(BETA-GAMMA)-BINDING PROTEIN
Authors: SCHULZ K DANNER S BAUER P SCHRODER S LOHSE MJ
Citation: K. Schulz et al., EXPRESSION OF PHOSDUCIN IN A PHOSDUCIN-NEGATIVE CELL-LINE REVEALS FUNCTIONS OF A G(BETA-GAMMA)-BINDING PROTEIN, The Journal of biological chemistry, 271(37), 1996, pp. 22546-22551
FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN 5,025 EUROPEAN PATIENTS WITH AIDS
Authors: LUNDGREN JD BARTON SE LAZZARIN A DANNER S GOEBEL FD PEHRSON P MULCAHY F KOSMIDIS J PEDERSEN C PHILLIPS AN CLUMECK N DEWIT S SOMMEREIJNS B NIELSEN JO LUNDGREN J NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL KATLAMA C BERLUREAU P DIETRICH M SCHWANDER S PAPADOPOULOS A BANHEGYI D YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S VELLA S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G CARGNEL A ARLOTTI M CIAMMARUGHI R COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W DARMINIO A SACCO L MIGNANI E NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R BLOEMKOLK D ANTUNES F PROENCA R GONZALEZLAHOZ J MARTINEZBLANCO L CLOTET B GATELL J BUIRA E MIRO J LUTHY R LEDERGERBER B OLSSON C GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJORUP I NIELSEN J NIEPORT C TEGLBJAERG L THORNVAL A
Citation: Jd. Lundgren et al., FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN 5,025 EUROPEAN PATIENTS WITH AIDS, Clinical infectious diseases, 21(1), 1995, pp. 106-113
INTRAVENOUS VERSUS ORAL GANCICLOVIR - EUROPEAN AUSTRALIAN COMPARATIVE-STUDY OF EFFICACY AND SAFETY IN THE PREVENTION OF CYTOMEGALOVIRUS RETINITIS RECURRENCE IN PATIENTS WITH AIDS
Authors: COOPER D MCCLUSKEY P MATHIESEN L BORME KK SKINHOJ P PRAUSE JU TINNING S BARTON S JOHNSON M MAIN J PINCHING A MIGDAL C KATLAMA C LEHOANG P MATHERON S COCHEREAU I ROZENBAUM W ZAZOUN L FABRICIUS EM GARWEG J ALBRECHT H KNOSPE V STOEHR A VANLUNTZEN J GOEBEL F DANNER S VANDENHORN J THOMSON M HENDERSON J
Citation: D. Cooper et al., INTRAVENOUS VERSUS ORAL GANCICLOVIR - EUROPEAN AUSTRALIAN COMPARATIVE-STUDY OF EFFICACY AND SAFETY IN THE PREVENTION OF CYTOMEGALOVIRUS RETINITIS RECURRENCE IN PATIENTS WITH AIDS, AIDS, 9(5), 1995, pp. 471-477
SURVIVAL DIFFERENCES IN EUROPEAN PATIENTS WITH AIDS, 1979-89
Authors: LUNDGREN JD PEDERSEN C CLUMECK N GATELL JM JOHNSON AM LEDERGERBER B VELLA S PHILLIPS A NIELSEN JO DEWIT S SOMMEREIJNS B NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL KATLAMA C BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G CARGNEL A ARLOTTI M CIAMMARUGHI R COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W LAZZARIN A MONFORTE AD MIGNANI E NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R DANNER S ANTUNES F PROENCA R GONZALEZLAHOZ J MARTINEZBLANCO L CLOTET B BUIRA E MIRO J PEHRSON P LUTHY R OLSSON C GLAUSER M HIRSCHEL B HAWKES S BARTON S MORCINEK J PINCHING A COLEMAN D
Citation: Jd. Lundgren et al., SURVIVAL DIFFERENCES IN EUROPEAN PATIENTS WITH AIDS, 1979-89, BMJ. British medical journal, 308(6936), 1994, pp. 1068-1073
COMPARISON OF LONG-TERM PROGNOSIS OF PATIENTS WITH AIDS TREATED AND NOT TREATED WITH ZIDOVUDINE
Authors: LUNDGREN JD PHILLIPS AN PEDERSEN C CLUMECK N GATELL JM JOHNSON AM LEDERGERBER B VELLA S NIELSEN JO DEWIT S SOMMEREIJNS B NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL KATLAMA C BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G CARGNEL A ARLOTTI M CIAMMARUGHI R COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W LAZZARIN A MONFORTE AD MIGNANI E NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R DANNER S BLOEMKOLK D ANTUNES F PROENCA R GONZALEZLAHOZ J MARTINEZBLANCO L CLOTET B GATELL J BUIRA E MIRO J PEHRSON P LUTHY R LEDERGERBER B OLSSON K GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJPRUP I NIELSEN J NIEPORT C TEGLBJAERG L THORNVAL A
Citation: Jd. Lundgren et al., COMPARISON OF LONG-TERM PROGNOSIS OF PATIENTS WITH AIDS TREATED AND NOT TREATED WITH ZIDOVUDINE, JAMA, the journal of the American Medical Association, 271(14), 1994, pp. 1088-1092
Risultati: 1-23 |